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High molecular weight (HMW) adiponectin levels are reduced in humans with type 2
diabetes and insulin resistance. Similar to humans with insulin resistance, managed bot-
tlenose dolphins (Tursiops truncatus) diagnosed with hemochromatosis (iron overload) have
higher levels of 2 h post-prandial plasma insulin than healthy controls. A parallel reaction
monitoring assay for dolphin serum adiponectin was developed based on tryptic peptides
identified by mass spectrometry. Using identified post-translational modifications, a dif-
ferential measurement was constructed. Total and unmodified adiponectin levels were
measured in sera from dolphins with (n=4) and without (n=5) iron overload.This measure-
ment yielded total adiponectin levels as well as site specific percent unmodified adiponectin
that may inversely correlate with HMW adiponectin. Differences in insulin levels between
iron overload cases and controls were observed 2 h post-prandial, but not during the fasting
state. Thus, post-prandial as well as fasting serum adiponectin levels were measured to
determine whether adiponectin and insulin would follow similar patterns.There was no dif-
ference in total adiponectin or percent unmodified adiponectin from case or control fasting
animals.There was no difference in post-prandial total adiponectin levels between case and
control dolphins (mean±SD) at 763±298 and 727±291 pmol/ml, respectively (p=0.91);
however, percent unmodified adiponectin was significantly higher in post-prandial cases
compared to controls (30.0± 6.3 versus 17.0±6.6%, respectively; p= 0.016). Interestingly,
both total and percent unmodified adiponectin were correlated with glucagon levels in
controls (r =0.999, p<0.001), but not in cases, which is possibly a reflection of insulin
resistance. Although total adiponectin levels were not significantly different, the elevated
percent unmodified adiponectin follows a trend similar to HMW adiponectin reported for
humans with metabolic disorders.
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INTRODUCTION
Managed dolphins have higher serum ferritin levels, total serum
iron levels, percent transferrin saturation, and total iron binding
capacity compared to free-ranging dolphins (1). Managed dol-
phins are also susceptible to hemochromatosis (iron overload)
where iron deposition in Kupffer cells is a prevalent diagnostic fea-
ture (2). While the cause of iron accumulation or iron overload is
not known, elevated post-prandial insulin levels in dolphins were
associated with excessive hepatic iron deposition (3). Humans with
elevated iron stores but without hemochromatosis can have clin-
ical laboratory values consistent with metabolic syndrome and
insulin resistance (4), and hepatic iron overload is associated with
insulin resistance regardless of the extent of liver damage (5).
Adiponectin is an adipokine primarily secreted by adipocytes
and is considered an insulin-sensitizing hormone. Low circulating
levels of adiponectin are associated with hyperinsulinemia (6),
high liver lipid content, and obesity (7). Recently, iron was impli-
cated in the direct negative regulation of adiponectin production
by adipocytes which resulted in insulin resistance in mice (8) sug-
gesting that the relationship between iron,adiponectin,and insulin
sensitivity are tightly intertwined. Previous findings of elevated 2 h
post-prandial serum insulin and glucagon levels in dolphins with
hemochromatosis compared to controls, suggest that dolphins
with iron overload may be unable to properly regulate insulin
levels (3); however it is not known whether this observed post-
prandial insulin and glucagon response is correlated with total
serum adiponectin.
Reports of blood adiponectin levels in marine mammals are
limited to a single species, Northern elephant seals (Mirounga
angustirostris), and were measured in pups using a canine ELISA
assay (9, 10). Interestingly, the mean levels reported were one to
two orders of magnitude lower than mean levels reported for
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dogs (11–13), suggesting that marine mammals may have low
circulating adiponectin levels, Northern elephant seals have low
adiponectin levels, or that the ELISA assay utilized had limited
cross-reactivity to elephant seal adiponectin. To assess true cross-
reactivity of an antibody, a fully recombinant adiponectin protein
is required, which is not commercially available for marine mam-
mals. Cross-reactivity concerns can be avoided by utilizing an
alternative mass spectrometry-based direct detection approach,
parallel reaction monitoring [PRM; (14, 15)]. This method is sim-
ilar to selected reaction monitoring (SRM) with the exception that
all product ions from a collision induced dissociation reaction are
monitored and available for extraction (16).
Adiponectin exists as multimers, commonly referred to as high
and low molecular weight (HMW and LMW). Multimerization
is largely governed by post-translational modifications (PTMs)
within the collagenous domain of the protein and glycosylation
following lysine hydroxylation is reported to be key in the forma-
tion of multimers as well as the ability to properly phosphorylate
AMP-kinase in liver tissue (17). Because HMW adiponectin is
best associated with diabetes and metabolic syndrome (18, 19)
and because glycosylation of lysine is an important modifica-
tion that drives intracellular AMP-kinase signaling, a new method
is presented to provide a differential measurement of tryptic
adiponectin peptides that could reflect some degree of lysine
modification to serve as a proxy of adiponectin modification
and possibly multimerization. This method relies on the differ-
ential measurement of total adiponectin and unmodified Lys75
adiponectin peptides to investigate whether degree of modification
is associated with outcome data. Therefore, it was hypothesized
that the fraction of total adiponectin that is unmodified at a known
lysine (Lys75) would be elevated in iron overload dolphins at the
2 h post-prandial time point compared to controls. Additionally, it
was hypothesized that 2 h post-prandial levels of total adiponectin
would be lower compared to a control group of dolphins.
MATERIALS AND METHODS
PRMMETHOD DEVELOPMENT SERUM
A single dolphin serum was used for PRM assay development,
taken from a 2.44 m long female bottlenose dolphin (SC-0145).
The dolphin was captured, sampled, and released on June 26, 2001
during a NOAA sponsored rescue and relocation operation of two
dolphins located in a fresh water reservoir near Charleston, South
Carolina. Both dolphins had moved into the freshwater reservoir
on June 6, 2001. The sample was stored at −80°C. Before pro-
cessing further, the serum was thawed at 37°C for 2–5 min, before
being aliquoted into 110µl aliquots which were frozen at −80°C.
These aliquots were used fresh daily by thawing at 37°C for 1 min
and mixed briefly by vortexing before use.
IRON OVERLOAD CASE-CONTROL STUDY POPULATION
The study population consisted of nine bottlenose dolphins at
the U.S. Navy Marine Mammal Program (MMP), including six
females and three males with ages ranging from 8 to 48 years. The
study included four dolphins with iron overload (cases) and five
controls. Iron overload cases in this study were previously reported
to have chronically elevated serum aminotransferases, specifically
alanine aminotransferase (ALT) and aspartate aminotransferase
(AST), as well as elevated serum iron (20). These four case animals
had since undergone phlebotomy treatments in order to manage
iron overload, and diagnoses of iron overload have been confirmed
by live liver biopsies in three of the four animals (21). Control ani-
mals had normal blood values throughout the year before sample
collection, specifically iron, ALT, and AST, based upon published
reference ranges for healthy bottlenose dolphins (22). Of these
control animals, one female surrogate was lactating and nursing a
calf and another was in the early stage of pregnancy during the 2 h
post-prandial phase.
IRON OVERLOAD CASE-CONTROL STUDY POPULATION DIET
Marine Mammal Program dolphins were fed high-quality, frozen-
thawed fish and mollusks, including capelin (Mallotus villosus),
herring (Clupea harengus), mackerel (Scomber scombrus), and
squid (Loligo brevis). They received daily vitamin supplementa-
tion that did not include iron, as well as periodic anti-parasitic
medications for prophylaxis. Proximate analysis was used to assess
nutrient concentration in fish fed during the study period. Crude
protein concentration was determined at Michelson Laboratories,
Inc. (Commerce, CA, USA) using standard methods (23). Fed pro-
tein was calculated using the protein concentration reported by
Michelson Labs along with daily food intake and animal weight.
Measurements for age, weight, and fed protein were based on col-
lection dates from 2 h post-prandial samples. If no length data
was available on the weight date, the nearest length measurement
was used. BMI was calculated using the standard human equation:
weight per square length (kilogram per square meter).
IRON OVERLOAD CASE-CONTROL STUDY SAMPLE COLLECTION
Marine Mammal Program dolphins are trained to voluntarily
allow collection of blood from the ventral fluke veins. Blood was
collected in BD Vacutainer (Rutherford, NJ, USA) blood collec-
tion tubes using 20- or 21-gage, 1.5′′ needles. Blood was collected
in ethylenediaminetetraacetic acid (EDTA), serum separator tubes
(SST), and red top tubes (no additive). One vial each of serum and
EDTA whole blood were submitted to Quest Diagnostic Laborato-
ries (San Diego, CA, USA) or the Naval Medical Center (San Diego,
CA, USA) for analysis of serum chemistry and complete blood
count (CBC). Remaining blood was centrifuged at 3000 rpm for
10 min and separated prior to archiving. Serum and plasma sam-
ples were stored frozen at −80°C until analysis. EDTA plasma
samples were processed and frozen within 30 min of blood col-
lection. Plasma was analyzed for insulin and glucagon at Esoterix
Inc., Laboratory Services (Calabasas Hills, CA, USA). The tests for
insulin and glucagon have not been validated in dolphins. Fast-
ing and 2 h post-prandial samples were 132–706 days (489 days on
average) apart.
SERUM HEMATOLOGICAL ANALYSIS AND CALCULATIONS
Serum biochemistry and CBC analyses were performed at the
Naval Medical Center using a Cobas 8000 Modular Analyzer Series
(Roche Diagnostics, Indianapolis, IN, USA) and Beckman Coul-
ter LH755 (Beckman Coulter, Brea, CA, USA), respectively, as well
as at Quest Diagnostics using a Coulter LH 750 (Beckman Coul-
ter, Fullerton, CA, USA) and Olympus AU600 (Olympus America,
Center Valley, PA, USA). Serum chemistry analyses included glu-
cose, sodium, potassium, chloride, carbon dioxide, anion gap,
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creatinine, blood urea nitrogen (BUN), uric acid, total bilirubin,
total protein, alkaline phosphatase (ALP), ALT, AST, lactate dehy-
drogenase (LDH), gamma-glutamyl transpeptidase (GGT), and
iron. CBC analyses included total white blood cell count with dif-
ferential, red blood cell count, hemoglobin, hematocrit, mean cor-
puscular volume, mean corpuscular hemoglobin, and mean cor-
puscular hemoglobin concentration (MCHC). EDTA plasma sam-
ples correlating to serum samples used were analyzed by Esoterix
Inc., Laboratory Services for total insulin and glucagon. Insulin
was measured by two-site manual immunochemiluminometric
assay (ICMA). Glucagon was measured by radioimmunoassay
(RIA) following addition of aprotinin injection (Trasylol®, Bayer
Pharmaceuticals Corporation, West Haven, CT, USA).
Homeostasis Model Assessment for Insulin Resistance
(HOMA-IR) was calculated using a standard equation used in
human endocrinology: [plasma insulin (µIU/ml)× serum glu-
cose (mg/dl)]/405 (24). Erythrocyte sedimentation rates (ESR;
60-min) were analyzed in-house from EDTA whole blood using
Fisherbrand Dispette 2®(Fisher Scientific, Waltham, MA, USA),
correlating with the Westergren method. Estimated glomerular
filtration rate (eGFR) was calculated using a dolphin-specific
equation based on serum creatinine (25).
REAGENTS AND CHEMICALS
All reagents were ACS grade or higher. Water and acetonitrile were
LC-MS grade (Honeywell Burdick and Jackson, Morristown, NJ,
USA). Solutions of ammonium bicarbonate, dithiothreitol (DTT),
and iodoacetamide (IAA) were made fresh each day. Only Protein
Lo-Bind (Eppendorf, Hamburg, Germany) microcentrifuge tubes
were used to minimize protein and peptide adsorption.
DEPLETED SERUM PREPARATION FOR TARGET PEPTIDE SELECTION
To confirm target proteotypic adiponectin peptides, an aliquot of
the “method development serum” was utilized. Protein concentra-
tions were determined by the Bio-Rad Protein assay (Hercules, CA,
USA) which is based on the Bradford method. A Multiple Affin-
ity Removal System (MARS) Human 14 spin cartridge (Agilent
Technologies, Santa Clara, CA, USA) was used to deplete 30µl of
serum (3× 10µl) which depleted the sample from 1000 to 139µg
protein. The resulting eluent was precipitated with acetone, then
reconstituted in RapiGest SF Surfactant (Waters, Milford, MA,
USA), reduced with 5 mM DTT, alkylated with 15 mM IAA, and
digested overnight with Promega Gold trypsin (Promega, Madi-
son, WI, USA) at an enzyme-to-protein ratio of 1:50 (w:w). The
digest was halted with 0.1% formic acid (v/v) and the resulting
peptides were desalted using a 30 mg Strata-X 33µ polymeric
reverse phase solid phase extraction column (Phenomenex, Tor-
rance, CA, USA), washed with 1 ml 5% acetonitrile in 0.1% formic
acid, and eluted with 1 ml 60% acetonitrile in 0.1% formic acid.
The eluent was dried under vacuum with spinning followed by
resuspension in mobile phase A (MPA) (98% water, 2% acetoni-
trile,0.1% formic acid) to a concentration of 0.25µg/µl protein (as
estimated by Abs280), and 10µl was injected onto the LC-MS/MS
as described below.
SYNTHETIC PEPTIDE STANDARDS
The following peptides were synthesized by New England Pep-
tide (Gardner, MA, USA) with isotopically labeled (“∧”; 13C
and 15N) c-terminus amino acids: IFYNQQSHYDGTTGK∧ (IFY)
and GDTGETGVTGVEGPR∧ (GDT). The manufacturer verified
labeled peptide concentration by amino acid analysis of an aliquot
made from 0.5 mg of each standard, after which 100µl aliquots at
approximately 200µM in 30% acetonitrile (v/v) 0.1% formic acid
(v/v) were frozen at −80°C. For collision energy optimizations,
external calibration curves, and sample analyses, fresh aliquots
were used by first thawing at 37°C for 1 min and then diluted in
10% acetonitrile (v/v) 0.1% formic acid (v/v) to achieve the desired
concentration.
PREPARATION OF TRYPTIC PEPTIDES FOR ANALYSIS
Prior to digesting the samples, a protocol was optimized for
digesting dolphin serum. The amount of serum, acid-cleavable
detergent, trypsin, and different desalting elutions were evaluated
to maximize assay sensitivity and eliminate sources of experimen-
tal error. The resulting protocol is as follows: frozen serum aliquots
were thawed at 37°C for 1 min and vortexed for 5 s. A 5µl aliquot
of serum was transferred to a 1.5 ml microcentrifuge tube, and
45µl 50 mM ammonium bicarbonate (AmBic) was added. To this
mixture, 50µl of 0.1% (w/v) Progenta™ Anionic Acid Labile Sur-
factant II (AALS2; Progenta™ Protea Biosciences, Morgantown,
WV, USA) dissolved in 50 mM AmBic was added and mixed by
pipetting. To this mixture 11µl of 1 M DTT (in 25 mM AmBic)
was added and incubated for 30 min at 60°C. The reaction was
allowed to cool 5 min before 12.5µl IAA (in 100 mM AmBic) was
added and incubated in the dark for 30 min at 37°C. The reac-
tion was brought to 200µl with 50 mM AmBic before trypsin was
added at an enzyme-to-protein ratio of 1:10 (w:w). Finally 100µl
100 mM AmBic was added and the digest was incubated for 16 h
at 37°C in the dark. After 16 h, the digest was stopped with the
addition of 350µl 1% formic acid (v/v), and left at room tem-
perature for 30 min to allow for the AALS2 to be cleaved. Next,
300µl of 0.1% formic acid was added to bring the final volume to
approximately 1 ml. Additionally, 30µl of a 100 fmol/µl internal
standard (IS) mix comprised of the two isotopically labeled pep-
tides in 10% acetonitrile (v/v) was added, which corresponded to
3000 fmol of each IS. Following the manufacturer’s protocol, the
complete volume was loaded onto a methanol-conditioned 30 mg
Strata-X 33µ polymeric reverse phase solid phase extraction col-
umn (Phenomenex, Torrance, CA, USA) and washed three times
with 0.1% formic acid followed by 5% acetonitrile (v/v) in 0.1%
formic acid. The peptides were eluted using 1 ml 15% acetoni-
trile in 0.1% formic acid. The elution was frozen at −80°C, and
dried under vacuum by speedvac. Next 100µl of MPA (98% water,
2% acetonitrile, 0.1% formic acid) was added, the sample was vor-
texed 15 min, centrifuged at 10,000× g for 5 min, and the resulting
supernatant was transferred to a clean 1.5 ml microcentrifuge tube.
At this stage, the sample protein concentration was approximately
7µg/µl (as estimated by Abs280), therefore prior to injection, 25µl
was diluted into 975µl of MPA, and was analyzed by LC-MS/MS.
LC-MS/MS
Prior to analysis by tandem mass spectrometry, the performance
of the LC-MS/MS was confirmed using a standard tryptic digest
of β-galactosidase by evaluating precursor retention times, and
fragment ion areas. Tryptic peptides (10µl) were injected onto
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a 100µm× 1 cm C18 (100 Å with 5-mm particles) trap column
(Acclaim PepMap 100; Thermo Fisher Scientific), and separated
on a 75µm× 15 cm C18 (300 Å with 3-µm particles) analytical
column (Acclaim PepMap 100; Thermo Fisher Scientific). Reverse
phase separation at 300 nl/min was performed with a gradient of
3–30% mobile phase B [95% acetonitrile (v/v), 0.1% formic acid
(v/v)] over 12 min on a 2D+ NanoLC system (Eksigent, Dublin,
CA, USA). The LC was interfaced to a TripleTOF 5600 System
(AB Sciex, Foster City, CA, USA) with a nanospray source. Source
temp was set at 120°C, and source voltage was set at 2500 V. The
declustering potential was set at 110 V. To identify target proteo-
typic peptides, the instrument was run in positive ion instrument
dependent acquisition mode with precursor ion scans for 250 ms
with up to 20 product ion scans of 50 ms if precursors were 300–
1250m/z, exceeded 125 cps, and had a 2+ to 5+ charge state. For
PRM experiments, the dominant charge state of each peptide was
chosen and collision energies were optimized for each peptide. In
one case the 2+ precursor was used, GDT, while the 3+ precur-
sor was used for IFY. Collision energies were optimized for each
peptide by monitoring the relative intensity of abundant fragment
ions that had an m/z greater than the precursor m/z. The value
which yielded the highest fragment ion area was used, which typ-
ically was close to the CE predicted by the equation determined
by Kuzyk et al. (26): CE= 0.043× (precursor ion m/z)+ 2.25. For
PRM, the instrument was set in positive ion mode and collected
TOF-MS data in a window of 450–1250m/z for 150 ms, followed
by each parent ion MS/MS for 400 ms, collecting data from 100 to
1600m/z. Due to the nature of the TripleTOF mass spectrometer,
all ion pairs were monitored. The precursor masses were cycled
such that the unlabeled peptide was collected, followed by the cor-
responding isotopically labeled peptide, before moving to the next
peptide. For each peptide the three fragment ions with highest
abundance were selected and used for PRM experiments (Figure
S1 and Table S1 in Supplementary Material).
PEPTIDE IDENTIFICATION
For determination of target peptides, raw data generated by the
AB Sciex 5600 were converted to a peak list using the AB Sciex
MS Data Converter (v. 1.1 beta, July 2011). Protein identifica-
tions were made using Mascot (v. 2.3.02) searching against the
Ensembl (release 64) turTru1 dolphin genome assembly protein
database [16,598 sequences; (27)] and the common Repository
of Adventitious Proteins database (cRAP; 2012.01.01; the Global
Proteome Machine) using the following parameters: trypsin was
selected as the enzyme and three missed cleavages were allowed;
carbamidomethylation (Cys) was specified as a fixed modifica-
tion; glucosylgalactosyl (Lys), oxidation (Met, Pro), and 2-succinyl
(Cys) were specified as variable modifications; a precursor toler-
ance of 10 ppm and fragment ion tolerance of 0.5 Da; instrument
type was ESI-QUAD-TOF. The mass spectrometry proteomics
data have been deposited to the ProteomeXchange Consortium
(http://proteomecentral.proteomexchange.org) via the PRIDE
partner repository (28) with the dataset identifier PXD000431.
EXTERNAL CALIBRATION CURVES AND ADIPONECTIN MEASUREMENT
An external calibration curve was constructed using a mix of both
labeled peptides in a digestion matrix with a peptide concentration
approximately the same as the test samples. This was accomplished
by digesting and processing the “method development serum”
sample using the optimized protocol. After SPE clean up, the digest
was brought up in 100µl MPA, and 5µl of this was diluted into
175µl MPA and 20µl of a 10× standard solution (for each cali-
bration point) resulting in approximately 0.5µg/µl protein digest.
Twelve concentrations of labeled peptide were used from 0.005 to
10 fmol/µl, and 10µl of each was injected onto the LC-MS/MS
in triplicate and the instrument acquired data as described above.
Quantitative measurements were calculated by using area under
the curve for ion pairs using the built-in MQ4 algorithm in Multi-
Quant (v 2.0.2, AB Sciex). The following parameters were used for
peak determination: 3.0 Gaussian smooth width, minimum peak
width of three points, minimum peak height of 0.00. Integration
parameters were as follows: 40% noise, 2 min baseline subtraction
window, four points peak splitting. Fragment ions were extracted
from each MS/MS experiment using a predicted monoisotopic
mass± 0.05m/z. Regression was performed using peak areas with
a linear fit and a 1/x weighting. There was a linear relationship
of instrument response to analyte concentration from 0.05 to
100 fmol for all peptides and relevant fragment ions (Figures S2–
S7 in Supplementary Material). Using the “best” ion pair for each
peptide (IFY y132+ and GDT y7), there was no concentration
that had relative standard deviations higher than 20%; therefore
experimental assay variability and limits of detection and quantifi-
cation were determined within experimental analysis as opposed
to using the external curve for such calculations. An experimental
blank was processed during each digestion batch, which was 5µl
phosphate buffered saline digested exactly the same as test sam-
ples, with 15µg trypsin used for digestion. This blank was used to
calculate the limit of detection (LOD) and limit of quantification
(LOQ) on the days of analysis. This was accomplished by measur-
ing the standard deviation of triplicate blank area measurements
and the following equations: (m= slope of external calibration
curve) LOD= 3 σ/m; LOQ= 10 σ/m (29). Additionally, one sam-
ple was digested in triplicate during each batch of digestion and
was analyzed to determine experimental variability. Lastly, a com-
posite serum sample was used as an in-house internal reference
material to correct between experimental batches. The peak areas
for the y132+ ion of IFY and the y7 ion of GDT of both the labeled
and unlabeled peptides were extracted with MultiQuant and used
to calculate the amount of adiponectin in samples. Experimental
variability was calculated using experimental triplicates and was
<15% RSD (Table S3 in Supplementary Material). Daily LOD and
LOQ were calculated for the assay and the serum measurements
were more than two orders of magnitude above LOQ. Additionally,
the IS area and the average analyte area were within one order of
magnitude. Taken together, these parameters indicated the assay
was performing with high sensitivity and precision. Lastly, the
measurement of IFY was used to indicate total adiponectin and the
measurement of GDT to indicate the amount of unmodified Lys75
adiponectin such that percent unmodified Lys75 adiponectin is:
(GDT/IFY)× 100.
STATISTICS
Wilcoxon rank-sum test was used to compare continuous variables
between two groups with both SAS (v 9.1, SAS Incorporated) and
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MATLAB (R2013a; Mathworks), and since there were fewer than
10 individuals per category, the exact test was performed. Fisher’s
exact test was used to compare categorical factors. Pearson Product
Table 1 | Identified adiponectin peptides and their modifications.
Position Peptide sequence and modifications Ion
score
Expect
value
57–90 DGSPGEKGEKGDPGFAGPKGDTGETGVT
GVEGPR
70 1.3E–6
3 Glucosylgalactosyl (K); Oxidation (P)
64–90 GEKGDPGFAGPKGDTGETGVTGVEGPR 41 6.7E–4
2 Glucosylgalactosyl (K)
76–90 GDTGETGVTGVEGPR 110 2.6E–5
91–98 GFPGIPGR 30 0.002
2 Oxidation (P)
99–110 KGEPGESAYVYR 103 5.4E–10
Glucosylgalactosyl (K)
111–120 SAFSVGLETR 62 4.2E–6
121–129 VTIPNVPIR 53 1.0E–5
133–147 IFYNQQSHYDGTTGK 75 1.1E–6
191–205 NVDQASGSVLLYLEK 72 4.0E–7
Tryptic peptides from dolphin adiponectin were identified by tandem mass spec-
trometry followed by database searching using Mascot. Modified residues pre-
dicted by Mascot are in bold and underlined, with modifications indicated below
each peptide sequence. Peptide position relative to the whole protein, Mascot
ion scores, and statistical probability of the identity match being random (Expect
Value) are presented.
Moment Correlation analysis was performed with SigmaPlot 11.0
(Systat Software).
RESULTS
DEVELOPMENT OF ADIPONECTIN ASSAY
In order to select proteotypic adiponectin peptides for quantifi-
cation by PRM, digested endogenous dolphin adiponectin was
analyzed by tandem mass spectrometry. Using a Tursiops trun-
catus protein database and by specifying known and predicted
adiponectin modifications (30–36) nine peptides were identi-
fied for a total of 43% coverage of the 242 amino acid dol-
phin adiponectin (Ensemble ID ENSTTRP00000015964; Table 1).
Three hydroxylated prolines (Pro60, Pro93, Pro96) and four gluco-
sylgalactosyl lysines (Lys63, Lys66, Lys75, Lys99) in the collagenous
domain were identified (Figure 1). There was no evidence of
succination (Cys). From the list of identified peptides and cor-
responding predicted chemical properties (e.g., solubility) two
target peptides were selected: IFYNQQSHYDGTTGK (IFY) and
GDTGETGVTGVEGPR (GDT). Sample processing and instru-
ment parameters were optimized to measure these two peptides in
dolphin serum using PRM.
IRON OVERLOAD CASE-CONTROL STUDY
While comparisons are limited based upon the small sample size,
there were no significant differences in gender, age, weight, length,
BMI, or diet between the two groups (Table 2). Blood values were
compared between cases and controls within the fasting and 2 h
post-prandial sample sets (Table 3). Within the fasting samples,
ALT and GGT were significantly higher in the iron overload group
(p= 0.0159 and 0.0476, respectively) while MCHC was signifi-
cantly lower (Table S2 in Supplementary Material; p= 0.0317)
compared to controls. Iron was not significantly different, which
was expected since the iron overload samples were taken post-
phlebotomy (21). Within the post-prandial set, ALT was also
FIGURE 1 | Observed dolphin adiponectin post-translational
modifications. Adiponectin residues were aligned using UniProt alignment
(ClustalO) with UniProt/SwissProt sequences and the Ensembl Tursiops
truncatus sequence. Signal peptides were removed and sequences manually
aligned around Human Thr20–Thr22 similar to Richards et al. (35). The collagen
domain was assigned based on G-X-Y-G repeats as in Wang et al. (33).
Assigned modifications for comparison are from previous studies of
adiponectin in human (32, 35), mouse (30, 34, 37), and cow (31). Modified
residues are in red, sialylation is represented as a lightning bolt, succination
represented as a red star, hydroxylation represented as OH encircled,
glycosylation [specifically, glucosyl-α(1,2)galactosylation] represented as black
hexagons in tandem.
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Table 2 | Study group characteristics table.
Characteristic Iron overload Control p-Value
SEX, N (%)
Female 2 (50%) 4 (80%) 0.524
Male 2 (50%) 1 (20%)
AGE (years)
Mean±SD 34.3±7.5 26±15.2 0.286
Median 32.4 26.9
Range 27.5–44.8 8–47.9
WEIGHT (kg)
Mean±SD 200.3±45.3 186.1±32.3 0.730
Median 196.8 172.3
Range 160–247.7 147.7–223.2
LENGTH (cm)
Mean±SD 261±20 253±8 0.857
Median 260 255
Range 241–284 242–264
BMI (kg/m2)
Mean±SD 29±2.4 29±4.5 0.556
Median 29.1 26.5
Range 26.5–31.4 25.2–36
FED PROTEIN (g/kg)
Mean±SD 6.3±1 6.6±1.4 0.556
Median 6.4 6.8
Range 4.9–7.2 5.1–8.4
All data is temporally related to the 2 h post-prandial sample set, and dietary data
is from the draw date’s protein load. Comparisons between the groups were
made using Fisher’s exact test for categorical factors and Wilcoxon rank-sum test
for continuous variables.
higher and MCHC (Table S2 in Supplementary Material) was
lower in the iron overload group (p= 0.0159 and 0.0159, respec-
tively) compared to controls. Additionally, total bilirubin, anion
gap (Table S2 in Supplementary Material), insulin, and HOMA-
IR were higher in the iron overload group (p= 0.0476, 0.0357,
0.0159, and 0.032, respectively) compared to controls. Specifi-
cally, insulin was 39.0± 18.8µIU/ml and 7.7± 5.8µIU/ml and
HOMA-IR scores were 10± 5 and 2± 1, for iron overload cases
and controls, respectively.
Total (IFY) and percent unmodified Lys75 adiponectin (GDT)
were compared between controls and iron overload cases within
fasting or post-prandial samples (Figure 2). Total adiponectin
was not different between the two groups either fasting or post-
prandial. The average total adiponectin (±SD) in the fasting
samples was 1233± 597 pmol/ml and 1245± 130 pmol/ml for
control and iron overload subjects, respectively. The average total
adiponectin in the post-prandial samples was 727± 291 pmol/ml
and 763± 298 pmol/ml for control and iron overload subjects,
respectively. Percent unmodified adiponectin was not different
between the two groups within the fasting samples at 20.2± 4.1
and 21.7± 6.9% in control and iron overload samples, respectively.
Percent unmodified adiponectin was significantly higher in iron
overload subjects within the post-prandial samples (p= 0.016) at
17.0± 6.6 and 30.0± 6.3% in control and iron overload subjects,
respectively. Using a threshold of greater than 23.1% unmodified
adiponectin, these two groups were completely separated in the
post-prandial samples.
Levels of total and percent unmodified adiponectin were also
compared to evaluate gender differences. In the fasting sam-
ple set, total adiponectin in males was 1362± 59 pmol/ml (with
26.7± 2.8% unmodified) and in females was 1177± 529 pmol/ml
(with 18.0± 3.2% unmodified). In the 2 h post-prandial sam-
ples, total adiponectin in males was 1023± 194 pmol/ml (with
25.3± 3.6% unmodified) and in females was 601± 183 (with
21.4± 11.1% unmodified).
Correlations were evaluated between metabolic variables, total
adiponectin, and percent unmodified adiponectin in the post-
prandial samples (Table 4). For the control group, total, and
percent unmodified adiponectin were significantly positively
correlated (p< 0.05) with each other. Both total and percent
unmodified adiponectin were significantly positively correlated
with glucagon levels (ρ= 0.934 and 0.999, respectively; p< 0.05;
Figure 3). Neither were significantly correlated to glucose, insulin
levels, or HOMA-IR. Comparing the same variables in the iron
overload subjects, there was no significant correlation. Specifi-
cally, the striking correlation of glucagon and percent unmodified
adiponectin in the controls (Figure 3A) was completely absent in
the iron overload cases (Figure 3B).
DISCUSSION
ASSAY DEVELOPMENT FOR DOLPHIN ADIPONECTIN
In this study tryptic peptides belonging to adiponectin from the
bottlenose dolphin were identified using liquid chromatography
tandem mass spectrometry. These peptides were used to develop
a reaction monitoring assay to quantify adiponectin in dolphin
serum. Since a high resolution mass spectrometer was used that
did not isolate individual fragment ions in a distal quadrupole, this
type of analysis has been termed PRM (16). Reaction monitor-
ing is gaining popularity as a tool for estimating protein quantity
using peptides derived from proteolytic digestion (14), with the
added benefit that it can be multiplexed and provides a level of
specificity through direct analyte detection that is not afforded
by antibody-based techniques. As this study highlights, one of the
more liberating aspects of reaction monitoring is the fact that it can
be quickly adapted to measure clinically relevant proteins in non-
model organisms if a protein sequence is known and proteolytic
peptides can be detected. Moreover, this data demonstrates that a
mid-abundance serum protein, adiponectin (0.06% of total serum
protein in the method development sample), can be quantified
without depletion or enrichment prior to analysis. Quantifying
proteins in this direct manner has been demonstrated before using
SRM (38–40).
The range of total adiponectin concentrations in the study pop-
ulation was 383–1827 pmol/ml, corresponding to 10–48µg/ml
adiponectin. This is within the reported range for humans (41),
mice (42), dogs (43), and cows (44) (see Table S4 in Supple-
mentary Material). In reference to reported adiponectin values
from the elephant seal (9, 10), order Carnivora, the dolphin lev-
els were approximately 20- to 170-fold higher, suggesting either a
massive difference in the circulating level of adiponectin between
marine mammals or a reflection of the assay utilized to measure
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Table 3 | Hematologic and serum biochemistry data of study group.
2 h post-prandial Fasting
Iron overload Control p-Value Iron overload Control p-Value
WBC (103/µl) 8.5±1.0 8.7±3.4 0.730 10.2±3.6 7.5±1.1 0.191
HGB (g/dl) 12.6±2.5 12.9±0.8 0.730 12.0±1.0 13.0±0.8 0.214
Platelets (103/µl) 57.3±23.0 78.2±18.5 0.191 78.8±14.6 104.0±36.1 0.286
Eosinophils (cells/µl) 746±266 1025±900 0.905 1024±638 1218±365 0.905
Glucose (mg/dl) 98±9 102±7 0.905 117±33 109±16 0.556
Protein (g/dl) 7.0±0.4 6.4±0.4 0.079 7.3±0.2 6.6±0.5 0.056
Albumin (g/dl) 4.2±1.9 4.9±0.3 0.960 5.0±0.8 4.2±0.3 0.214
Globulins (g/dl) – – – 2.9±0.1 2.4±0.3 0.095
ALP (U/l) 290±152 320±100 0.730 259±134 262±104 0.905
LDH (U/l) 476±106 455±55 1.000 462±147 346±70 0.214
AST (U/l) 275±49 190±111 0.191 346±97 229±100 0.191
ALT (U/l) 40±5 27±6 0.016* 56±9 29±8 0.016*
GGT (U/l) 50±18 29±7 0.079 66±35 30±9 0.048*
Bilirubin (mg/dl) 0.2±0.1 0.0±0.1 0.048* 0.2±0.1 0.1±0.1 0.119
Cholesterol (mg/dl) 234±92 203±25 1.000 245±71 199±29 0.286
Triglycerides (mg/dl) 101±10 101±36 0.786 124±86 71±18 0.191
Fe (µg/dl) 205±65 162±65 0.413 210±85 159±29 0.516
ESR (mm/h) 8±11 13±6 0.413 15±21 9±6 0.849
eGFR (ml/min/2.78m2) 217±30 271±32 0.087 199±8 243±39 0.119
Insulin (µIU/ml) 39±19 8±6 0.016* 14±12 17±17 0.849
Glucagon (pg/ml) 155±54 87±54 0.286 – – –
HOMA-IR 10±5 2±1 0.032* 4±4 5±5 0.730
AWilcoxon rank-sum test was used to compare blood chemistry values between groups, and significance indicated by “*” if p<0.05. A complete table of hematologic
and serum biochemistry values can be found in Table S2 in Supplementary Material.
FIGURE 2 |Total and percent unmodified adiponectin levels in
post-prandial and fasting samples. (A) Two hours post-prandial and
(B) fasting sample sets. Squares are total adiponectin and triangles are
percent unmodified adiponectin. Solid symbols are controls and hollow
symbols are iron overload cases. An “*” indicates significance difference
(p<0.05) when comparing the groups.
adiponectin. Comparative generalizations made across mammals
would be premature at this stage due to lack of standardization of
assay methodology.
Adiponectin exists as a variety of multimers, dictated by PTMs
in the collagenous domain. Oligomerization is key to direct-
ing the receptor-mediated biological activities of adiponectin.
For instance, monomeric adiponectin produced by recombi-
nant bacterial systems does not form HMW multimers com-
pared to adiponectin produced by mammalian expression systems,
and thus does not repress serum glucose (45, 46). Further, the
amount of HMW adiponectin (18–30+ protomers) but not total
adiponectin correlates to improved insulin sensitivity in mice and
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Table 4 | Pearson product moment correlations (ρ) of variables within groups in the 2 h post-prandial sample set.
Unmodified adiponectin (%) Glucose Insulin Glucagon HOMA-IR
CONTROL GROUP
Total adiponectin ρ=0.940 ρ=0.160 ρ=0.257 ρ=0.934 ρ=0.260
p=0.0174* p=0.797 p=0.676 p=0.0204* p=0.672
Unmodified adiponectin (%) – ρ=0.136 ρ=0.393 ρ=0.999 ρ=0.404
– p=0.828 p=0.512 p<0.001* p=0.500
IRON OVERLOAD GROUP
Total adiponectin ρ=−0.245 ρ=0.725 ρ=−0.370 ρ=0.927 ρ=−0.266
p=0.755 p=0.275 p=0.630 p=0.0727 p=0.734
Unmodified adiponectin (%) – ρ=−0.485 ρ=−0.607 ρ=−0.432 ρ=−0.623
– p=0.515 p=0.393 p=0.568 p=0.377
Correlations between metabolic variables were evaluated within controls and iron overload cases. Significant correlations are indicated by “*”, p<0.05.
FIGURE 3 | Glucagon and percent unmodified adiponectin levels in the
2 h post-prandial samples. The linear regression in (A) control group
(n= 5) was r = 0.999, p<0.001, and in the (B) iron overload group (n=4)
was r =0.432, p=0.568.
humans with type 2 diabetes mellitus (47). Although oligomer for-
mation is dependent on disulfide bond formation at Cys34 (34),
lysine, and proline modifications within the collagenous domain
are also required [reviewed in Ref. (33)]. For example, the level
of HMW adiponectin is directly related to the extent of which
the four conserved lysine residues are modified (17), while proline
hydroxylation likely promotes rapid folding and thermostability,
like that for other collagen-like domains (48). Further, published
mutagenesis studies of four conserved adiponectin lysine residues
demonstrated a shift in production from HMW to LMW multi-
mers (17, 32). Together this suggests that the biological activity of
adiponectin is directly related to the modification of key residues.
POST-TRANSLATIONAL MODIFICATION AND RATIOMETRIC
MEASUREMENT OF DOLPHIN ADIPONECTIN
A search of tandem mass spectra from dolphin serum tryptic
peptides was performed to determine whether known lysine and
proline modifications were present on dolphin adiponectin. Glu-
cosylgalactosyl modification of four lysines, Lys63, Lys66, Lys75,
and Lys99 (Figure 1; Table 1), were identified which are conserved
across mammals, though there was no evidence for glucosylgalac-
tosyl modification of Lys31 reported for bovine adiponectin (31).
There was also hydroxylation at proline residues Pro60, Pro93,
and Pro96. The identification of hydroxylation at Pro60 (but not
Pro69) was supported by b- and y-ion series, although hydroxyla-
tion of the human equivalent of Pro69 (but not Pro60) has been
described [human Pro71; (32)]. Overall, these results confirm dol-
phin adiponectin can be modified at key lysine and proline residues
in the collagenous domain, though it is unclear exactly how the
degree of modification affects oligomerization.
In this study, a new method to measure adiponectin was
developed by measuring two quantotypic tryptic peptides, IFY
and GDT, by PRM. To date, two other studies have used more
than one peptide to quantify adiponectin by reaction monitoring.
Homologs of IFY and GDT have been used to quantify human
adiponectin (49), while more recently, GFPGIQGR as well as
human IFY have been targeted for measurement (50). These pep-
tides are located within the collagenous domain (GFPGIQGR and
GDT) and globular domain (IFY; Figure 1). Using the human
homologs of IFY and GDT as well as the same fragment ions as this
study, Domanski et al. found IFY was threefold higher than GDT in
a pooled sample of human plasma (49). Likewise IFY was on aver-
age fivefold higher than GDT in dolphin serum. Interestingly, the
GDT homolog in humans contains an additional proline (human
Pro86), and both prolines (human Pro86 and Pro 91) have been
shown to be hydroxylated (32, 35). Because the GDT measure-
ment was based on measuring the unmodified peptide, it would
be affected by either proline hydroxylation. In the current study,
oxidation of dolphin Pro89 was not identified. In addition to inter-
nal proline residues, GDT is surrounded by proline (32) and lysine
(33) residues known to be modified. Modification of Lys75 is likely
to prohibit cleavage by trypsin at this residue and therefore result
in lower levels of GDT compared to IFY. This is also supported
by the observation of two additional peptides with mis-cleavages
after a modified Lys75 (Table 1). In the case of GFPGIQGR, it
is expected that human Lys101 and Pro95 modifications may be
limiting cleavage and measurement, respectively, resulting in the
sixfold lower measurement of this unmodified peptide versus the
GDT homolog in a pooled human plasma (50).
Since Lys75 modification is relevant to the multimerization
of and formation of HMW adiponectin, percent unmodified
adiponectin at Lys75 was determined using the ratio of GDT to
IFY. The percent unmodified Lys75 adiponectin in the study pop-
ulation was between 8 and 39%, suggesting that 61 to 92% of
the adiponectin is modified at Lys75. The percentage of modified
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adiponectin is similar to levels of HMW adiponectin reported for
humans [30–50%; (51)], cats [50%; (52)], and dogs [80%; (43)].
For this reason the level of percent unmodified Lys75 appears to be
a proxy of multimeric adiponectin, although further validation is
necessary to determine the distribution of this modification across
different multimers.
COMPARISON OF TOTAL ADIPONECTIN LEVELS IN DOLPHINS WITH
IRON OVERLOAD
The hypothesis was tested that total adiponectin levels in dol-
phins with iron overload and putative insulin resistance have
lower adiponectin levels compared to control dolphins. Serum
levels were measured at two different states; fasting and 2 h post-
prandial, the later state being the one at which both insulin and
glucagon were elevated in the animals with iron overload com-
pared to control animals [see Ref. (3)]. To avoid misrepresentation,
blood samples were not drawn on the same day, but rather at com-
pletely different subsequent periods of time as stated in the meth-
ods. There was no statistical difference between total adiponectin
levels in dolphins with iron overload versus controls during fast
or 2 h post-prandial; therefore this hypothesis was rejected. The
absolute amount of modified adiponectin as a proxy of multimeric
HMW adiponectin was calculated based on the unmodified Lys75
peptide (i.e., GDT). There was no significant difference between
iron overload cases and control dolphins regardless of fasting or
feeding (data not shown). Although low total adiponectin lev-
els have been reported in patients with non-alcoholic fatty liver
disease (53) and inversely associated with serum ferritin and trans-
ferrin (54), total adiponectin does not appear to correspond to
insulin resistance promoted by iron overload in dolphins.
Of note, the effect of gender and age on the level of adiponectin
may be confounding in a small study population such as the
one utilized in this study. In humans total adiponectin levels are
higher in females than males, and increases with age in both sexes
[reviewed by Brochu-Gaudreau et al. (55)]. Although the gender
differences were not significantly different between both groups,
females comprised 80% of the control group and 50% of the case
group. Incongruent to that reported for other mammals, males
tended to have higher total adiponectin levels and percent unmod-
ified adiponectin than did females when dolphins were grouped by
gender alone and classified by fasting or 2 h post-prandial. Based
on this data, the group with the higher percentage of females (con-
trol) could have biased the result such that the hypothesis was less
likely to have been accepted. Due to a limited number of animals
available for study, caution should be taken when extrapolating
interpretation of results to the population level, but also high-
lights the need for a future study with a larger frequency matched
population.
RATIOMETRIC MEASUREMENT OF ADIPONECTIN IN DOLPHINS WITH
IRON OVERLOAD
Because a reduction in the fraction of HMW adiponectin occurs
in response to insulin or glucose administration in mice (56) and
because the ratio of HMW to total adiponectin is correlated to
improved hepatic insulin sensitivity (47), the fraction of unmodi-
fied Lys75 (i.e., GDT) adiponectin was measured in dolphins with
iron overload and an insulin resistant phenotype. Although this
assay has not yet been validated as a direct measure of multi-
meric forms of adiponectin (e.g., HMW adiponectin), the fact
that lysine hydroxylation is correlated with adiponectin multi-
merization led us to speculate that the direct measurement of
unmodified Lys75 (GDT) peptide relative to the total adiponectin
peptide (IFY) could serve as a proxy for probable multimeriza-
tion. If this assumption is valid, then the ratio of unmodified
Lys75 peptide (GDT) to total adiponectin peptide (IFY) should
be elevated in dolphins with iron overload at 2 h post-prandial
because these animals have elevated insulin levels. During fasting,
both groups of dolphins were essentially equivalent in the percent
unmodified adiponectin; however, at 2 h post-prandial the percent
of unmodified adiponectin was significantly higher in the iron
overload cases (Figure 2). The elevation in 2 h post-prandial per-
cent unmodified adiponectin in iron overload cases corresponds
well to the fractional response of HMW adiponectin following
oral glucose load or intraperitoneal insulin load in mice (56). The
increase in percent unmodified Lys75 (GDT) peptide relative to
the total adiponectin peptide (IFY) at the 2 h post-prandial time
point also corresponded well with the elevated levels of insulin and
glucagon reported by Venn-Watson et al. (3). These results sup-
port the assertion that GDT:IFY may serve as a proxy for HMW
adiponectin multimers, but further studies are needed to confirm
this speculation.
CORRELATION OF ADIPONECTIN WITH GLUCAGON
To further explore additional relationships between the total
and ratiometric measurements of adiponectin, the Pearson prod-
uct moment correlations between adiponectin measurements
and select serum biochemistry values were calculated (Table 4).
Interestingly, only glucagon levels correlated with the total and
ratiometric measurements of adiponectin in the control group.
When plotted against glucagon, the ratiometric measurement of
adiponectin results in a nearly perfect linear relationship with
glucagon levels in control dolphins; whereas, in dolphins with iron
overload there was no correlation (Figure 3). The discriminatory
value of this relationship as a classifier for metabolic insufficiency is
very strong and could potentially be valuable as a marker of hepatic
insulin improvement such as that reported for humans (47).
To the authors’ knowledge, there are no previous studies
describing such a relationship between glucagon and adiponectin
in healthy mammals. A weak correlation between hepatic arter-
ial adiponectin and glucagon was previously reported for patients
with liver cirrhosis (57) and the authors speculated that the rea-
son was because clearance routes were similar for both hormones;
however, there was no correlation between total adiponectin and
glucagon in dolphins with iron overload where hepatic dysfunc-
tion is more prevalent (2). It is possible that in healthy mammals,
serum glucagon and adiponectin multimer concentrations are
tightly controlled through mechanisms of clearance and that the
correlation is lost in dolphins with hepatic dysfunction where
glucagon is unable to be efficiently cleared and/or only higher
molecular weight adiponectin is selectively cleared. In pigs, the
clearance of glucagon largely occurs through elimination via the
kidney and in dogs the fraction of glucagon extracted by the liver
is only approximately 20% (58) suggesting that renal clearance,
not hepatic clearance is the main sink. In this study there was
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no difference in eGFR between dolphin groups indicating that
impaired renal clearance is an unlikely reason for preferential clear-
ance of adiponectin forms. Adiponectin is cleared by both the liver
and kidneys in mice with a half-life of about 75 min (59). How-
ever, adiponectin clearance does not appear to be as important as
production in determining total serum adiponectin. In an obese,
hyperinsulinemic mouse model (ob/ob), circulating adiponectin
levels are low despite the fact that clearance is reduced suggest-
ing that adiponectin production is disproportionately depressed
(59). Further, hyperinsulinemia is known to reduce the circulat-
ing amount of HMV adiponectin independent of clearance (19),
which corresponds to the idea that impaired insulin-signaling is a
major determinant of adiponectin level (33).
Another potential mechanism connecting both adiponectin
and glucagon centers around the ability of fibroblast growth factor
21 (FGF21) to suppress glucagon (60) and stimulate adiponectin
secretion (61). FGF21 is a primarily liver derived fasting hor-
mone that has been shown to reduce HOMA-IR, triglyceride
levels, and blood glucose in the db/db mice when administered
exogenously (62). Although speculative, the lack of correlation
between glucagon and adiponectin in iron-overloaded dolphins
might be partially explained by an inability to elevate FGF21 levels
or a resistance to FGF21 signaling leading to improperly elevated
glucagon levels and reduction in modified adiponectin. Because
the link between FGF21, adiponectin, glucagon, and insulin resis-
tance is very strong, future studies should consider measurements
of FGF21 in dolphins. Taken together with the fact that insulin
is a negative regulator of glucagon, and that dolphins with iron
overload have significantly higher HOMA-IR scores, the evidence
suggest that the higher ratio of GDT to IFY is most likely an effect
of lower secretion of modified adiponectin coupled with improper
glucagon feedback control.
ADIPONECTIN AS AN ANTI-INFLAMMATORY
Adiponectin is known to have other roles in addition to insulin sen-
sitization one of which being as an anti-inflammatory mediator.
Because there was no intergroup difference in ESR (Table 3), which
is an indirect marker of inflammation, the correlation between sys-
temic inflammation and circulating adiponectin in dolphins was
not evident in this study. However, a hallmark feature of liver
disease due to iron overload in dolphins is the accumulation of
iron primarily in Kuppfer cells (macrophages) of the liver (2). The
globular domain of adiponectin has been shown to elevate IL-10
and heme oxygenase 1 (HO-1), and reduce TNFα expression in
Kupffer cells stimulated with lipopolysaccharide (63, 64). Given
that inactivation of Kupffer with gadolinium chloride prevents
ethanol-induced fatty liver disease in rats (65), any reduction in
the efficacy of adiponectin to promote IL-10 and reduce TNFα
could promote the fatty liver phenotype afflicting dolphins with
iron overload. Although the effect of extracellular iron has not been
reported with regards to dynamics of adiponectin modification,
high iron has been shown to reduce total adiponectin in adipocytes
(8). If proper adiponectin modification is necessary to suppress
inflammation due to activated Kupffer cells, then it is possible
that the link between non-alcoholic fatty liver disease, hemochro-
matosis and percent unmodified adiponectin could underlie the
metabolic disorders that ensue.
FUTURE QUESTIONS AND CONCLUSION
A number of basic questions remain unanswered with regards to
adiponectin in dolphins. Based on a search of the dolphin genome,
genes for adiponectin receptors R1,R2,and T-cadherin are present.
Therefore, it is likely that homologous receptors for signaling
exist in dolphins, but whether tissue receptor expression parallels
human and rodent models and whether cell signal transduc-
tion pathways are conserved across species, remains to be estab-
lished. Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (a.k.a.
lysyl hydroxylase 3; Ensembl ID: ENSTTRG00000004781) is also
present suggesting that differential enzyme activity responsible
for lysine hydroxylation and subsequent glucosylgalactosylation of
adiponectin in mice could underlie differences in the ratio of GDT
to IFY (37). Whether or not adipocytes are the major source of
adiponectin as in other mammals (33), remains to be determined.
In conclusion, an assay for adiponectin in dolphins has been
established that relies on the highly specific measurement of tryp-
tic peptides of adiponectin by PRM. Using this assay to study
a small group of dolphins with iron overload has provided fur-
ther insight into the hormonal dysregulation present in these
animals. Moreover, these results highlight that a differential ratio-
metric measurement using two quantotypic peptides may serve as
a marker of metabolic perturbations or improvement in dolphins.
Future studies will address whether these peptide ratios can be
used to determine the level of adiponectin modification and the
relationship to degree of oligomerization. By defining a more pre-
cise adiponectin oligomer distribution along a continuum, more
correlations with study endpoints could be evaluated. Because
of the high sequence similarity between human and dolphin
adiponectin and the presence of homologous gene products within
both species, these findings may be directly applicable to the mech-
anistic understanding of both dolphin and human metabolism.
AUTHORS CONTRIBUTION
Benjamin A. Neely contributed to the development of the assay,
to the experimental design, carried out analysis on the mass spec-
trometer, handled data processing, and drafted the manuscript.
Kevin P. Carlin contributed to the experimental design, gathering
sample data, data processing, and assisted in drafting the man-
uscript. John M. Arthur assisted in the interpretation of mass
spectrometry data, critical analysis of the assay design, and draft-
ing the manuscript. Wayne E. McFee procured the original serum
sample for the development of the assay and assisted in the writing
and review of the manuscript. Michael G. Janech conceived of the
assay and study, contributed to the development of the assay, to
the experimental design, and assisted in drafting the manuscript.
All authors read and approved the final manuscript.
ACKNOWLEDGMENTS
The authors wish to acknowledge Dr. Stephanie Venn-Watson
for her insightful discussions and facilitating the procurement
of samples from her original study. The authors would also like
to thank the animal care and training staff, interns, and veteri-
nary technicians at the U.S. Navy Marine Mammal Program for
their assistance with data and sample collection/processing. The
Nephrology Proteomics Laboratory at MUSC was instrumental in
the development of analytical techniques for this study. This study
Frontiers in Endocrinology | Diabetes September 2013 | Volume 4 | Article 132 | 10
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Neely et al. Measurements of dolphin serum adiponectin
was supported by the Office of Naval Research Award Number
N000141210294 and a ShEEP equipment grant from the Depart-
ment of Veterans’ Affairs. The bottlenose dolphin capture was
performed under the National Oceanic and Atmospheric Admin-
istration’s (NOAA) responsibility to respond to stranded, injured,
and/or out-of-habitat marine mammals under the Marine Mam-
mal Health and Stranding Response Act, 1992 (Title IV of Marine
Mammal Protection Act). The authors also wish to acknowledge
the National Marine Fisheries Service, South Carolina Marine
Mammal Stranding Network, South Carolina Department of Nat-
ural Resources, U.S. Navy, and all the volunteers that assisted with
the successful capture and release of the two bottlenose dolphins.
This publication does not constitute an endorsement of any com-
mercial product or intend to be an opinion beyond scientific or
other results obtained by NOAA. No reference shall be made to
NOAA, or this publication furnished by NOAA, to any advertising
or sales promotion which would indicate or imply that NOAA rec-
ommends or endorses any proprietary product mentioned herein,
or which has as its purpose an interest to cause the advertised
product to be used or purchased because of this publication. The
contents do not necessarily represent the views of the Department
of Veterans Affairs or the United States Government.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online at
http://www.frontiersin.org/Diabetes/10.3389/fendo.2013.00132/
abstract
Figure S1 | Fragmentation tables of three synthetic isotopically labeled
target peptides along with observed fragment ions. Tables of fragment ion
m/z is shown for each peptide (generated using the Institute for Systems
Biology online Fragment Ion Calculator; http://db.systemsbiology.net/
proteomicsToolkit/index.html). Observed fragment ions with highest peak
intensities are labeled in MS/MS spectra, and colored red in tables.
Figure S2 | External calibration curves for yl32+ from IFYNQQSHYDGTTGK.
The solid line represents the 1/x weighted linear regression, R = 0.99181. Inset
is provided to show performance at lower concentrations.
Figure S3 | External calibration curves for yl42+ from IFYNQQSHYDGTTGK.
The solid line represents the 1/x weighted linear regression, R = 0.98945. Inset
is provided to show performance at lower concentrations.
Figure S4 | External calibration curves for yl22+ from IFYNQQSHYDGTTGK.
The solid line represents the 1/x weighted linear regression, R = 0.99056. Inset
is provided to show performance at lower concentrations.
Figure S5 | External calibration curves for y7 from GDTGETGVTGVEGPR.
The solid line represents the 1/x weighted linear regression, R = 0.99278. Inset
is provided to show performance at lower concentrations.
Figure S6 | External calibration curves for y9 from GDTGETGVTGVEGPR.
The solid line represents the 1/x weighted linear regression, R = 0.9873. Inset is
provided to show performance at lower concentrations.
Figure S7 | External calibration curves for yl0 from GDTGETGVTGVEGPR.
The solid line represents the 1/x weighted linear regression, R = 0.98691. Inset
is provided to show performance at lower concentrations.
Table S1 | Ion pairs and instrument parameters used for PRM. Each
endogenous target peptide had an isotopically labeled synthetic version
constructed with either a C-terminal 8Lys or 10Arg, designated by a “∧” and
referred to as heavy. Fragment ion peak areas were extracted from each MS/MS
experiment using these monoisotopic masses ± 0.05 m/z.
Table S2 | Complete hematologic and serum biochemistry data of study
group. A Wilcoxon rank-sum test was used to compare blood chemistry values
between groups.
Table S3 | Assay performance measures. To evaluate assay performance on
the days of analysis, experimental triplicates were used quantify assay variability
and detection limits. The average peak area ratio was determined based on all
samples analyzed.
Table S4 | Measured adiponectin concentrations in blood from different
organisms using different techniques. Reported adiponectin measurements
by ELISA are typically microgram per milliliter therefore concentrations were
converted using the molecular weight of adiponectin from each species (an
elephant seal was assumed to be exactly 26 kDa).
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